Pennsylvania-based Third Arc Bio, a biotech company developing novel multifunctional antibodies for a range of oncology and immunology & inflammation (I&I) indications, has announced the closing of a ...
Massive Bio and ConcertAI revealed the AI oncology trial systems at SCOPE 2026.
US AI-focused start-up Formation Bio has entered a deal with Jiangsu Chia Tai Feng Hai Pharmaceutical (CTFH) for the ...
Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn’s ...
Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...
Swiss start-ups highlight that Europe must secure its place in venture capital alongside leading US specialists.
Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's ...
Industry leaders have said the Union Budget 2026 has laid the groundwork for a major shift in India's pharmaceutical sector, with the Biopharma SHAKTI initiative expected to reduce reliance on ...
Morning Overview on MSN
Scientists trial shocking ER-100 drug that could reverse human aging
For decades, the idea of a drug that could rewind aspects of human aging has belonged more to science fiction than hospital formularies. That boundary is starting to blur as a gene therapy called ...
SEOUL, 서울 – SEOUL, SOUTH KOREA, January 28, 2026 / EINPresswire.com / — LEESOL, a South Korea–based sleep and mental wellness technology company, announced today that its sleep and mental health ...
A comprehensive new market research report titled Industrial Silicones Market Size, Future Growth and Forecast 2033 reveals ...
As the smallest model in the lineup, the new 13-inch Samsung Color E-Paper offers businesses a compact display option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results